The Sheffield Biomedical Research Centre has been awarded £12 million to fund research into cutting edge medical treatments.
The National Institute for Health Research Sheffield Biomedical Research Centre (NIHR Sheffield BRC) is a partnership between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, founded in 2017.
The new funding will allow research for the next five years into immune disorders, cardiovascular diseases, as well as helping to improve care for patients living with HIV.
Director of the NIHR Sheffield BRC Professor Dame Pamela Shaw said:
“This new round of funding will allow the centre to continue this important work and develop a portfolio of promising new therapeutic approaches.
“It will also create opportunities for the next generation of clinical and scientific researchers working to improve the lives of those living in South Yorkshire, a region that still suffers from lower life expectancy and wider health inequalities.”
“The Sheffield Biomedical Research Centre has a track record of giving access to experimental medical trials for patients living with a variety of diseases, including neurodegenerative diseases such as MND, Parkinson’s, and multiple sclerosis.
“This work has improved the outlook in multiple ways for patients facing devastating neurological conditions.”
Kirsten Major, Chief Executive of Sheffield Teaching Hospitals NHS Foundation Trust, added:
“We are absolutely delighted that our bid for an additional £12 million funding has been successful.
“This means we can expand the ground-breaking research we do in partnership with the University of Sheffield which impacts on the future care and treatment of so many patients not just locally but worldwide.
“The enlarged Biomedical Research Centre will allow even more of our patients to participate in research which we know in itself also improves patients’ health and outcomes.”
The NICR Sheffield BRC has already conducted 304 clinical studies and has given 2,974 experimental treatments and therapies to patients.